Partnership to drive brand architecture, go-to-market execution, and global launch of the Company’s product portfolio bridging biotechnology and premium skincare MELVILLE, N.Y., April 07, 2026 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX,” or the “Company”) (Nasdaq:BRTX), a late-stage clinical regenerative medicine company focused on stem cell-based therapies and products, today announced a strategic collaboration with 203 Creates, LLC, a Stamford, Connecticut-based firm specializing in the development, marketing, and growth of luxury, premium, and science-backed brands. The collaboration is designed to advance BioRestorative’s biocosmeceutical platform by establishing a differentiated brand architecture and executing a comprehensive commercialization strategy. Pursuant to the agreement between 203...

BEVERLY, Mass., April 07, 2026 (GLOBE NEWSWIRE) — ATN International, Inc. (“ATN” or the “Company”) (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, today announced its Board of Directors has appointed Naji Khoury as President and Chief Executive Officer, effective April 20, 2026. Mr. Khoury succeeds Brad Martin, who is stepping down as Chief Executive Officer and member of the Company’s Board of Directors and will remain in an advisory capacity through the end of May 2026 to support a smooth transition. Mr. Khoury is an industry leader with nearly 30 years of experience in the telecommunications sector. Prior to joining ATN, he spent 14 years at Liberty Communications Puerto Rico, including the last six years as Chief Executive Officer, where he oversaw operations in Puerto Rico and the U.S....

Nasdaq confirms Company has regained compliance with Listing Rules 5550(b)(1) and 5620(a) SOLANA BEACH, Calif., April 07, 2026 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical‑stage pharmaceutical company focused on modulating lipid‑signaling pathways to develop treatments for people living with cancer, pain, dermatological, or neurological conditions, today announced that it has received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), the “Equity Rule,” and Listing Rule 5620(a), the “Annual Shareholders Meeting Rule.” Nasdaq further confirmed that, based on the Company’s Form 8-K filed January 30, 2026, the Company held its reconvened annual meeting on that date and, based on the Company’s Form 8-K filed March 30,...

Chief Executive Officer Jan Goetgeluk to Present at Private, Invitation-Only Dinner at Mar-a-Lago with Investors and Senior Government Officials AUSTIN, Texas, April 07, 2026 (GLOBE NEWSWIRE) — Virtuix Inc. (NASDAQ: VTIX), a leading developer of full-body virtual reality systems, today announced that Chief Executive Officer Jan Goetgeluk will present at a private, invitation-only roundtable taking place April 16, 2026, at the Mar-a-Lago Club in Palm Beach, Florida. Mr. Goetgeluk will meet with an exclusive group of institutional investors, high-net-worth individuals and senior government officials at Mar-a-Lago and also present at an investor lunch in West Palm Beach earlier in the day on April 16, 2026. Mr. Goetgeluk will discuss the Company’s growing traction for the Omni technology in the defense sector, with recent sales...

Texas agency’s initial purchase of BolaWrap devices, WrapTactics subscriptions, and in-person training supports broader expansion of tools, training, and policy-aligned NLR capabilities MIAMI, April 07, 2026 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in Non-Lethal Response (“NLR”) and public safety technology, today announced that the Galveston Police Department in Texas has adopted Wrap’s NLR solutions through the purchase of BolaWrap 150® devices and WrapTactics™ subscriptions, supported by in-person training. Wrap also expects additional expansion purchases to support broader deployment of NLR capabilities across various units within the department. Galveston Police Department serves a coastal community with an emphasis on personal security, community engagement,...

Det skal herved oplyses, at det nu igen er muligt at stille indre værdier i nedenstående afdelinger, hvorfor Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen A/S om, at suspension ophæves.  Ophævelsen gælder nedenstående afdelinger: Fund Name ISIN Order Book CodeINDEX Bæredygtige Virksomhedsobligationer HY KL DK0016028020 SPVBVOINDEX Emerging Market Bonds Lokalvaluta DK0060254043 SPVINOINDEX Emerging Market Bonds Lokalvaluta Akk. – KL A DK0060254126 SPVINOAKKKLAINDEX Globale Aktier KL DK0060747822 SPVIGAKLINDEX Globale Aktier Min. Risiko Akk. KL DK0060748127 SPVIGAMRAKLINDEX Bæredygtige Global KL DK0060747905 SPVIBGKLINDEX Bæredygtige USA KL DK0060748200 SPVBUSAKLINDEX Bæredygtige Europa KL DK0060748044 SPVBEUKLINDEX Lav Risiko KL DK0060748556 SPVILRKLINDEX Mellem Risiko KL DK0060748630 SPVIMRKLINDEX...

LONDON and NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced that it will hold a key Scientific Advisory Board (SAB) meeting with leading ophthalmology experts during the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in Washington, DC. The SAB meeting, scheduled to take place alongside the conference, will bring together prominent corneal and ocular surface disease specialists to review clinical data for the company’s lead candidate, urcosimod and provide strategic guidance on the upcoming clinical program. In conjunction with the SAB meeting, Dr. Pedram Hamrah, Professor of Ophthalmology,...

TORONTO, April 07, 2026 (GLOBE NEWSWIRE) — Highlander Silver Corp. (TSX, NYSE American: HSLV) (“Highlander Silver” or the “Company”) is pleased to provide a portfolio update following the successful completion of its combination with Bear Creek Mining (see press release dated February 26, 2026). Daniel Earle, President and CEO of Highlander Silver, commented: “Highlander Silver is well positioned to fast-track project advancement across its portfolio of high-quality silver assets. This includes a focus on high-impact exploration, project optimization, and site preparation for development of Corani, the largest fully permitted primary silver project in the world, as well as permitting at San Luis, one of the highest M&I resource grade projects in both the gold and silver sectors. As of March 31, the Company had an unaudited...

Baker Hughes to supply three NovaLT™16 gas turbines with three centrifugal compressors and related services for a pipeline project to support Argentina’s LNG exports These gas compression units mark the first use of Baker Hughes’ NovaLT™ gas turbine technology in South America, reflecting growing demand for high-efficiency, lower-emissions turbomachineryHOUSTON and LONDON, April 07, 2026 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR), an energy technology company, announced Tuesday it has secured a strategic order from San Matias Pipeline S.A. to supply three gas compression units for a major natural gas pipeline project in Argentina. The order consists of three NovaLT™16 gas turbines equipped with three centrifugal compressors, along with commissioning services, spare parts, special tools, and remote monitoring...

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences   Data highlights mechanism of action, outcomes in VLUs and DFUs, and comparative advantages over SANTYL® Findings support ongoing VALUE Phase III study and planned expansion into DFUs and pressure ulcers YAVNE, Israel, April 7, 2026 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced multiple oral and poster presentations at three leading wound care conferences: the Wound Healing Society (WHS) and the Symposium on Advanced Wound Care (SAWC) Spring 2026, taking place April 8–12 in Charlotte, North Carolina, and the European Wound Management Association (EWMA) 2026, taking place May 6–8 in Bremen, Germany. The presentations will showcase new preclinical and clinical data supporting...